Changchun BCHT Biotechnology Co. (SHA:688276)
China · Delayed Price · Currency is CNY 17.95
+0.45 (2.57%)
Sep 30, 2026, 3:00 PM CST
SHA:688276 Revenue
Changchun BCHT Biotechnology Co. had revenue of 157.16M CNY in the quarter ending June 30, 2026, with 28.19% growth. This brings the company's revenue in the last twelve months to 624.69M, down -30.25% year-over-year. In the year 2025, Changchun BCHT Biotechnology Co. had annual revenue of 605.07M, down -50.77%.
Revenue (ttm)
624.69M
Revenue Growth
-30.25%
P/S Ratio
11.89
Revenue / Employee
509.54K
Employees
1,226
Market Cap
7.43B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 605.07M | -624.01M | -50.77% |
| Dec 31, 2024 | 1.23B | -595.60M | -32.64% |
| Dec 31, 2023 | 1.82B | 753.24M | 70.30% |
| Dec 31, 2022 | 1.07B | -130.58M | -10.86% |
| Dec 31, 2021 | 1.20B | -239.33M | -16.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Taiji Industry(Group) Co.,Ltd | 9.93B |
| Renhe Pharmacy Co.,Ltd | 3.65B |
| Beijing Foyou Pharma CO.,LTD | 3.58B |
| Tianjin Ringpu Bio-Technology | 3.41B |
| Zhejiang Tianyu Pharmaceutical | 3.30B |
| Tianjin Tianyao Pharmaceuticals | 2.63B |
| Jiuzhitang | 2.60B |
| Guilin Sanjin Pharmaceutical | 2.02B |